Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/91028
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBarratt, D.-
dc.contributor.authorBandak, B.-
dc.contributor.authorKlepstad, P.-
dc.contributor.authorDale, O.-
dc.contributor.authorKaasa, S.-
dc.contributor.authorChristrup, L.-
dc.contributor.authorTuke, J.-
dc.contributor.authorSomogyi, A.-
dc.date.issued2014-
dc.identifier.citationPharmacogenetics and Genomics, 2014; 24(4):185-194-
dc.identifier.issn1744-6872-
dc.identifier.issn1744-6880-
dc.identifier.urihttp://hdl.handle.net/2440/91028-
dc.description.abstractAbstract not available-
dc.description.statementofresponsibilityDaniel T. Barratt, Benedikte Bandak, Pål Klepstad, Ola Dale, Stein Kaasa, Lona L. Christrup, Jonathan Tuke, Andrew A. Somogyi-
dc.language.isoen-
dc.publisherLippincott, Williams & Wilkins-
dc.rights© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins-
dc.source.urihttp://dx.doi.org/10.1097/fpc.0000000000000032-
dc.subjectcancer; cytochrome P-450 CYP3A; fentanyl; pain management; pharmacogenetics; pharmacokinetics; transdermal patch-
dc.titleGenetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study-
dc.typeJournal article-
dc.identifier.doi10.1097/FPC.0000000000000032-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1011521-
pubs.publication-statusPublished-
dc.identifier.orcidBarratt, D. [0000-0001-6261-353X]-
dc.identifier.orcidTuke, J. [0000-0002-1688-8951]-
dc.identifier.orcidSomogyi, A. [0000-0003-4779-0380]-
Appears in Collections:Aurora harvest 2
Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.